Literature DB >> 22183425

Chitotriosidase, interleukin-1 beta and tumor necrosis factor alpha levels in mild preeclampsia.

Ibrahim Alanbay1, Hakan Coksuer, Cihangir Mutlu Ercan, Yusuf Ustun, Gursoy Pala, Kazim Emre Karasahin, Ozlem Ozturk, Ismail Kurt, Iskender Baser.   

Abstract

OBJECTIVE: Chitotriosidase (ChT) is an activated macrophage marker. Tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β) are mainly produced macrophages. The aim of the present study was to evaluate the relationship between serum ChT activity, levels of TNF-α and IL-1β in patients with mild preeclampsia and normal pregnancy.
METHODS: An overall 64 cases, 32 healthy pregnant control women (control group) and 32 women with mild preeclamptic patients (study group), were enrolled in this study. At the beginning of the study, all study participants were matched for age and gestational age. Serum ChT activity was measured by fluorometer; TNF-α and IL-1β levels were measured by enzyme-linked immunosorbent assay.
RESULTS: The mean age, gestational week, parity and gravida were similar in the two groups (p > 0.05). Serum ChT activity was significantly higher in the preeclampsia group compared to the control group (p < 0.05). Levels of TNF-α and IL-1β in patients with mild preeclampsia were similar compared to the control group (p > 0.05). In the PE group, serum ChT activity was not correlated with TNF-α and IL-1β.
CONCLUSION: Mild preeclampsia is found associated with higher ChT activity. This result suggests that activated macrophages play a role in the pathogenesis of preeclampsia. This suggestion needs to be confirmed in future studies with larger populations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183425     DOI: 10.1007/s00404-011-2157-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

1.  Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.

Authors:  Kelly K Ferguson; John D Meeker; Thomas F McElrath; Bhramar Mukherjee; David E Cantonwine
Journal:  Am J Obstet Gynecol       Date:  2016-12-30       Impact factor: 8.661

2.  Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls.

Authors:  Brandie D Taylor; Gong Tang; Roberta B Ness; Jørn Olsen; David M Hougaard; Kristin Skogstrand; James M Roberts; Catherine L Haggerty
Journal:  Pregnancy Hypertens       Date:  2015-11-10       Impact factor: 2.899

3.  IL‑1β‑induced pentraxin 3 inhibits the proliferation, invasion and cell cycle of trophoblasts in preeclampsia and is suppressed by IL‑1β antagonists.

Authors:  Xiaoxi Wang; Jing Zhang; Jing Ji
Journal:  Mol Med Rep       Date:  2022-02-09       Impact factor: 2.952

4.  Decreased seizure threshold in an eclampsia-like model induced in pregnant rats with lipopolysaccharide and pentylenetetrazol treatments.

Authors:  Qian Huang; Lei Liu; Bihui Hu; Xiaodan Di; Shaun Patrick Brennecke; Huishu Liu
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

5.  Interleukin-1β-31C/T and -511T/C polymorphisms were associated with preeclampsia in Chinese Han population.

Authors:  Xuefeng Wang; Fengli Jiang; Yu Liang; Lina Xu; Hongbo Li; Yali Liu; Shiguo Liu; Yuanhua Ye
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.